A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Clinical trial NCT06823167 · RECRUITING

Trial details

NCT number: NCT06823167
Sponsor: Immunome, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Malignancies Hematologic Malignancies

Start date: 2025-02-26
Primary completion: 2028-05-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.